In support, previous studies have shown that MTR chemotherapy induces immunogenic cancer cell death, which releases danger signals that promote DC maturation and presentation of tumor antigens to CD4+ T cells, polarizing them towards antitumor IFN-γ-producing T helper 1 (Th1) responses [33]. The gene discussed is CD4; the disease is cancer.